
Fox Chase Cancer Center
- Thoracic Malignancies: A Review of the Latest Evidence
- 2022 Management of Early Stage Non-Small Cell Lung Cancer
- 2022 Optimizing Treatment Strategies for Localized and Advanced Prostate Cancer
- 19th Annual Highlights of the 2020 San Antonio Breast Cancer Symposium
- Genitourinary Malignancies in the Time of COVID-19
- Videos
- 2019 Updates in Bladder and Kidney Cancer
- Events
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
2019 Updates in the Management of Non-Muscle Invasive Bladder Cancer: Enhanced Cystoscopy, Urine Markers After Diagnosis, Chemotherapy Options and Checkpoint Inhibition
698 views
November 22, 2019
J. Ryan Mark, MD, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
Dr. ...
read more ↘ Mark is an Assistant Professor at the Sidney Kimmel Medical College at Thomas Jefferson University. His clinical practice is in all aspects of urologic oncology, with additional interest in minimally invasive approaches for the treatment of advanced genitourinary malignancies. He is a member of the Sidney Kimmel Cancer Center and the multidisciplinary management team in urologic oncology.
Dr. Mark completed his undergraduate studies at the University of Missouri, his medical degree at Saint Louis University, his internship and residency at Thomas Jefferson University Hospital, and his fellowship in urologic oncology at the Levine Cancer Institute at the Carolinas Medical Center.
↖ read less
Dr. ...
read more ↘ Mark is an Assistant Professor at the Sidney Kimmel Medical College at Thomas Jefferson University. His clinical practice is in all aspects of urologic oncology, with additional interest in minimally invasive approaches for the treatment of advanced genitourinary malignancies. He is a member of the Sidney Kimmel Cancer Center and the multidisciplinary management team in urologic oncology.
Dr. Mark completed his undergraduate studies at the University of Missouri, his medical degree at Saint Louis University, his internship and residency at Thomas Jefferson University Hospital, and his fellowship in urologic oncology at the Levine Cancer Institute at the Carolinas Medical Center.
↖ read less
Comments 0
Login to view comments.
Click here to Login
2019 Updates in Bladder and Kidney Cancer